$0.42
▲ +$0.03
(+7.69%)
Vol 1.3M
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$93.5M
ROE
-32.1%
Margin
-4.3%
D/E
226.57
Beta
1.14
52W
$1–$3
Wall Street Consensus
8 analysts · Apr 20264
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.11 | $-0.11 | +$0.00 |
| Sep 2025 | $-0.06 | $-0.14 | $-0.08 |
| Jun 2025 | $0.02 | $0.00 | $-0.02 |
| Mar 2025 | $-0.05 | $-0.01 | +$0.04 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $116.2M | $113.2M | $127.5M | $93.9M | $102.2M |
| Net Income | $2.5M | -$1.3M | $1.1M | -$21.7M | -$13.8M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -2.8% | 1.4% | -2.8% | -2.8% | -32.1% | -32.1% |
| P/E (TTM) | — | 251.90 | — | — | — | — |
| Net Margin | 0.9% | 0.1% | -0.3% | -0.3% | -4.3% | -4.3% |
| Gross Margin | 30.6% | 31.5% | 32.0% | 32.0% | 30.9% | 30.9% |
| D/E Ratio | 168.19 | 350.49 | 168.19 | 168.19 | 226.57 | 226.57 |
| Current Ratio | 1.65 | 1.64 | 1.65 | 1.65 | 1.56 | 1.56 |
Key Ratios
ROA (TTM)
-4.1%
P/S (TTM)
0.21
P/B
1.7
EPS (TTM)
$-0.16
CF/Share
$-0.02
Rev Growth 3Y
+2.2%
52W High
$2.95
52W Low
$0.81
$0.81
52-Week Range
$2.95
Financial Health
Free Cash Flow
-$21.6M
Net Debt
$132.9M
Cash
$41.3M
Total Debt
$174.2M
As of Dec 31, 2025
How does ARAY compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
ARAY valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0.2
▼
92%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
1.7
▼
37%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
ARAY profitability vs Health Care peers
ROE
-32.1%
▲
17%
above
peers
(-38.5%)
vs Peers
vs Industry
Below avg
Net margin
-4.3%
▲
83%
above
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
30.9%
▼
42%
below
peers
(52.9%)
vs Peers
vs Industry
Weak
ROA
-4.1%
▲
81%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
ARAY financial health vs Health Care peers
D/E ratio
226.6
▲
1075%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
1.6
▼
28%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
1.1
▲
8%
above
peers
(1.1)
vs Peers
vs Industry
Less volatile
ARAY fundamentals radar
ARAY
Peer median
Industry
ARAY profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ARAY vs peers: key metrics
Latest News
No related news yet